FUNDING News
Anti-aging startup NewLimit raises $435M at $3B+ valuation, eyes clinic in 2027
NewLimit, an anti-aging startup, has secured a significant $435 million Series C funding round, pushing its valuation past $3 billion. This substantial investment will accelerate the development of it
Isomorphic Labs Secures Over $2B to Scale AI Drug Discovery Platform
Alphabet's Isomorphic Labs, a Google DeepMind spin-off, has raised over $2 billion in new funding to expand its AI drug discovery engine beyond protein structure prediction. The significant Series B r
Isomorphic Labs Secures $2.1 Billion Series B for AI Drug Discovery
Isomorphic Labs, an AI drug discovery firm, has successfully raised $2.1 billion in a Series B funding round. The substantial investment, led by Thrive Capital and including participation from MGX and
Isomorphic Labs Secures $2.1B Series B for AI Drug Discovery Scale-Up
Isomorphic Labs, an AI-driven drug discovery company and a spin-off of Google DeepMind, has successfully raised $2.1 billion in Series B financing. This substantial investment will be utilized to furt
Isomorphic Labs Secures $2.1 Billion Series B for AI Drug Discovery
Alphabet's AI-driven drug discovery company, Isomorphic Labs, has raised $2.1 billion in a Series B funding round. This substantial investment, led by Thrive Capital, will be used to advance its pipel
Isomorphic Labs Secures $2.1 Billion in Series B Funding for AI Drug Discovery
Isomorphic Labs, an Alphabet-backed company focused on leveraging artificial intelligence for drug discovery, has successfully closed a $2.1 billion Series B funding round. This substantial investment
Isomorphic Labs Raises $2.1B Series B for AI Drug Design Engine
Isomorphic Labs, an Alphabet subsidiary, has secured $2.1 billion in Series B funding to advance its AI-first drug design and development platform. Led by Thrive Capital, this significant investment w
Isomorphic Labs Secures $2.1 Billion for AI Drug Design Engine
Isomorphic Labs, an AI-first drug design and development company spun off from Google DeepMind, has closed a $2.1 billion Series B funding round. Led by Thrive Capital, with participation from Alphabe
Isomorphic Labs Secures $2.1B Series B for AI Drug Discovery
Isomorphic Labs, an Alphabet-backed company, has raised $2.1 billion in Series B funding led by Thrive Capital. This significant investment aims to accelerate the firm's AI-driven drug discovery effor
Google's Isomorphic Labs to raise over $2 billion in new funding
Isomorphic Labs, Alphabet's AI drug discovery firm, is reportedly in advanced discussions to secure over $2 billion in a new funding round. Led by Thrive Capital with participation from Alphabet, this
Basata Secures $21M Series A for AI in Healthcare Automation
Basata announced a successful $21 million Series A funding round, led by Basis Set Ventures, to advance its AI-powered platform for automating healthcare administrative workflows. The company's AI age
Tempus Secures $400 Million in Upsized Convertible Senior Notes Offering
Tempus AI, a technology company focused on advancing precision medicine through artificial intelligence, has priced an upsized offering of $400.0 million in convertible senior notes due 2032. The net
Google's Isomorphic Labs seeks $2B to scale AI drug discovery efforts
Isomorphic Labs, the Alphabet-owned company focused on leveraging AI for drug discovery, is reportedly seeking over $2 billion in new funding. This significant capital raise highlights the increasing
Biohub Commits $500M to AI for Predictive Human Cell Models
The Chan Zuckerberg Biohub has launched a $500 million Virtual Biology Initiative to create AI-powered predictive models of the human cell. This global effort, in collaboration with institutions like
Turkey-Based Biotech Startup PhiTech Raises $2.4M for Precision Medicine
PhiTech, a Turkish deep-tech biotech startup, has successfully raised $2.4 million in its third funding round. This investment will fuel the development and global patenting of its AI-based multi-omic
Generare Secures €20M Series A for AI-Driven Drug Discovery
Paris-based techbio company Generare has successfully raised €20 million in Series A funding, co-led by Alven and Daphni. This investment will enable the company to expand its proprietary dataset of s
Generare raises $23.2M for AI drug discovery of novel molecules
Generare Bioscience SAS, a Paris-based biotechnology company, has successfully closed a Series A funding round, raising €20 million (approximately $23.3 million). The financing, co-led by Alven and Da
EvoBio AI Secures $50M Series B for Generative Protein Design Platform
EvoBio AI, a biotechnology startup leveraging generative AI for novel protein design, announced a $50 million Series B funding round. The investment will accelerate the development of its platform, wh
Earendil Labs, an AI-powered drugmaker, hauls in $787M
Earendil Labs, an AI-powered startup with a presence in China and the U.S., has secured $787 million in funding to advance its pipeline of biologic medicines for autoimmune conditions and cancer. The
Earendil Labs Secures $787M for AI-Powered Biologic Drug Discovery
Earendil Labs, an AI-powered drug discovery startup operating in both China and the U.S., has successfully raised $787 million in funding. This substantial investment, backed by firms like Dimension a
Verily Secures $300M for Precision Health AI, Alphabet Shifts Role
Verily, formerly an Alphabet company, has secured a significant $300 million investment round led by Series X Capital, with Alphabet transitioning to a significant minority investor. This funding will
metaBIX Biotech Raises $1.3M for AI Biosurveillance
Uruguayan deeptech startup metaBIX Biotech has successfully closed a $1.3 million funding round led by Dalus Capital and EWA Capital, with participation from existing investors. This investment will f
Owkin Spinout Waiv Raises $33M for AI-Powered Cancer Precision Testing
French AI biotech Owkin has spun out its diagnostics division, now named Waiv, securing $33 million in Series A funding. Led by OTB Ventures and Alpha Intelligence Capital, Waiv will focus on scaling
Alibaba Leads $72.7M Investment in BCI Startup StairMed
StairMed, a Brain-Computer Interface (BCI) developer, has successfully closed a RMB 500 million (USD 72.7 million) funding round. This significant investment was led by Alibaba Group, with additional
CRISPR Therapeutics Plans $350 Million Private Debt Offering
CRISPR Therapeutics announced plans for a private offering of $350 million in convertible senior notes, scheduled to mature in 2031. This funding initiative aims to support the company's ongoing gene-
Neurotech Startup Science Corp. Secures $230M at $1.5B Valuation
Science Corp., a neurotech startup dedicated to restoring eyesight, has successfully raised $230 million in a new funding round. This significant investment has boosted the company's valuation to $1.5
Bill Gates Awards $7M Grant to Belgian Startup Using AI for Climate-Resilient Crops
Belgian agtech firm Rainbow Crops has been awarded a $7 million grant from the Gates Foundation to advance its AI-driven technology for creating climate-resilient and high-yielding crops. The funding
Cognito Therapeutics Closes $105M Series C, Nexcure Raises $19M Series A
Cognito Therapeutics has successfully closed an oversubscribed $105 million Series C financing round, aimed at accelerating its neurodegenerative disease programs. Concurrently, Nexcure launched a $19
Syndex Bio closes $15.5M seed round, unveils mcPCR platform
Syndex Bio, a Cambridge, UK-based biotech startup, successfully closed an oversubscribed $15.5 million seed financing round led by ARCH Venture Partners. The company also unveiled its methyl-copying P
Paris' baCta Raises €7M Seed for AI-Powered Bioproduction
Paris-based industrial biotech startup baCta secured €7 million in seed funding led by LocalGlobe and Daphni. The company focuses on using AI-powered bioproduction to create industrial ingredients, ai
Deepinder Goyal's Temple Raises $54M for Brain-Monitoring Wearable
Deepinder Goyal, co-founder of Zomato, has secured $54 million in a seed funding round for his new wearable technology startup, Temple. The company is developing a high-performance wearable device des
Kerala University Boosts AI Research in Cancer, Cardiac Care
Kerala University's 2026-27 budget includes significant funding to advance AI-driven cancer and cardiac research, as well as introduce 40 new postgraduate programs in emerging interdisciplinary domain
DeepCell AI Secures $75M Series C to Advance Single-Cell Analysis
DeepCell AI has successfully closed a $75 million Series C funding round to accelerate the development and deployment of its AI-powered platform for high-throughput single-cell classification and phen
Generate Biomedicines' $400M IPO Puts AI Drug Discovery in Focus
Generate Biomedicines, an AI-driven drug developer, successfully completed its U.S. initial public offering (IPO) on February 26, 2026, raising $400 million. The company sold 25 million shares at $16
Generate Biomedicines Raises $400M in Largest Biotech IPO
AI drug discovery specialist Generate Biomedicines raised $400 million in the year's largest biotechnology initial public offering, selling 25 million shares at $16 each. Their shares began trading on
Turbine Secures $25M Series B, Announces New Top 10 Pharma Immunology Partnership
Turbine, a virtual biology company, has successfully closed a $25 million Series B funding round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors. This
Turbine Secures $25M Series B for AI Virtual Biology, Expands to Immunology
Budapest-based Turbine, a virtual biology company, has successfully closed a $25 million Series B funding round to further develop its AI-powered virtual cell platform. The company also announced a ne
Peptris Secures $7.7M Series A for AI Drug Discovery Programs
Bengaluru-based Peptris has closed a $7.7 million Series A funding round, co-led by IAN Alpha Fund and Speciale Invest. This capital injection will accelerate the company's AI-powered drug discovery i
GenoAI Therapeutics Secures $50M Series B for AI Precision Oncology
GenoAI Therapeutics announced a successful $50 million Series B funding round led by Venture Health Capital. This capital infusion will accelerate the development and expansion of its AI-powered platf